Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.64M Buy
369,189
+295,005
+398% +$6.96M ﹤0.01% 946
2026
Q1
$1.69M Buy
74,184
+1,677
+2% +$39.6K ﹤0.01% 1145
2025
Q4
$1.93M Buy
72,507
+62,705
+640% +$1.85M ﹤0.01% 1167
2025
Q3
$306K Hold
9,802
﹤0.01% 1452
2025
Q2
$328K Buy
9,802
+9,762
+24,405% +$323K ﹤0.01% 1479
2025
Q1
$1.35K Hold
40
﹤0.01% 2002
2024
Q4
$1.83K Buy
+40
New +$1.76K ﹤0.01% 1994
2023
Q3
Sell
-13,817
Closed -$873K 2023
2023
Q2
$873K Buy
+13,817
New +$787K ﹤0.01% 1292

Other funds holding ENOV

Amundi's ENOV Position: Q2 2026 in Review

Amundi increased its Enovis (ENOV) stake by 398% in Q2 2026, buying an estimated $6.96M and bringing the position to 369,189 shares worth $7.64M. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Amundi first reported a position in ENOV in Q2 2023 and has held it in 8 quarters since. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Amundi held 369,189 shares of Enovis worth $7.64M as of Q2 2026.
  • Amundi bought 295,005 Enovis shares in Q2 2026, an estimated $6.96M.
  • Enovis made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #946 holding.
  • Amundi first reported a position in Enovis in Q2 2023 and has held it in 8 quarters since.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.